Literature DB >> 28511285

Association of Increased F4/80high Macrophages With Suppression of Serum-Transfer Arthritis in Mice With Reduced FLIP in Myeloid Cells.

Qi-Quan Huang1, Robert Birkett1, Renee E Doyle1, G Kenneth Haines2, Harris Perlman1, Bo Shi1, Philip Homan1, Lianping Xing3, Richard M Pope1.   

Abstract

OBJECTIVE: Macrophages are critical in the pathogenesis of rheumatoid arthritis (RA). We recently demonstrated that FLIP is necessary for the differentiation and/or survival of macrophages. We also showed that FLIP is highly expressed in RA synovial macrophages. This study was undertaken to determine if a reduction in FLIP in mouse macrophages reduces synovial tissue macrophages and ameliorates serum-transfer arthritis.
METHODS: Mice with Flip deleted in myeloid cells (Flipf/f LysMc/+ mice) and littermate controls were used. Arthritis was induced by intraperitoneal injection of K/BxN serum. Disease severity was evaluated by clinical score and change in ankle thickness, and joints were examined by histology and immunohistochemistry. Cells were isolated from the ankles and bone marrow of the mice and examined by flow cytometry, real-time quantitative reverse transcriptase-polymerase chain reaction, or Western blotting.
RESULTS: In contrast to expectations, Flipf/f LysMc/+ mice developed more severe arthritis early in the clinical course, but peak arthritis was attenuated and the resolution phase more complete than in control mice. Prior to the induction of serum-transfer arthritis, the number of tissue-resident macrophages was reduced. On day 9 after arthritis induction, the number of F4/80high macrophages in the joints of the Flipf/f LysMc/+ mice was not decreased, but increased. FLIP was reduced in the F4/80high macrophages in the ankles of the Flipf/f LysMc/+ mice, while F4/80high macrophages expressed an antiinflammatory phenotype in both the Flipf/f LysMc/+ and control mice.
CONCLUSION: Our observations suggest that reducing FLIP in macrophages by increasing the number of antiinflammatory macrophages may be an effective therapeutic approach to suppress inflammation, depending on the disease stage.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28511285      PMCID: PMC5575965          DOI: 10.1002/art.40151

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  38 in total

1.  The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.

Authors:  T Kataoka; R C Budd; N Holler; M Thome; F Martinon; M Irmler; K Burns; M Hahne; N Kennedy; M Kovacsovics; J Tschopp
Journal:  Curr Biol       Date:  2000-06-01       Impact factor: 10.834

2.  Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Renee E Koessler; Robert Birkett; Andrea Dorfleutner; Harris Perlman; G Kenneth Haines; Christian Stehlik; Christopher V Nicchitta; Richard M Pope
Journal:  Arthritis Rheum       Date:  2012-11

3.  An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway.

Authors:  Akihito Nakajima; Sachiko Komazawa-Sakon; Mutsuhiro Takekawa; Tomonari Sasazuki; Wen-Chen Yeh; Hideo Yagita; Ko Okumura; Hiroyasu Nakano
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

4.  A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages.

Authors:  Hong-Liang Li; Ai-Bing Wang; Ran Zhang; Yu-Sheng Wei; Hou-Zao Chen; Zhi-Gang She; Yue Huang; De-Pei Liu; Chih-Chuan Liang
Journal:  J Cell Physiol       Date:  2006-08       Impact factor: 6.384

5.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

6.  Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways.

Authors:  Jessica M Haverkamp; Amber M Smith; Ricardo Weinlich; Christopher P Dillon; Joseph E Qualls; Geoffrey Neale; Brian Koss; Young Kim; Vincenzo Bronte; Marco J Herold; Douglas R Green; Joseph T Opferman; Peter J Murray
Journal:  Immunity       Date:  2014-12-11       Impact factor: 31.745

7.  Synovial tissue macrophage populations and articular damage in rheumatoid arthritis.

Authors:  D Mulherin; O Fitzgerald; B Bresnihan
Journal:  Arthritis Rheum       Date:  1996-01

8.  TNFalpha-induced macrophage death via caspase-dependent and independent pathways.

Authors:  Tri M Tran; Vladislav Temkin; Bo Shi; Lisa Pagliari; Soizic Daniel; Christiane Ferran; Richard M Pope
Journal:  Apoptosis       Date:  2009-03       Impact factor: 4.677

9.  The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.

Authors:  Alexander Golks; Dirk Brenner; Peter H Krammer; Inna N Lavrik
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

10.  CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis.

Authors:  Qi-Quan Huang; Harris Perlman; Robert Birkett; Renee Doyle; Deyu Fang; G Kenneth Haines; William Robinson; Syamal Datta; Zan Huang; Quan-Zhen Li; Hyewon Phee; Richard M Pope
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

View more
  10 in total

1.  Experimental arthritis: FLIPping the switch on macrophages.

Authors:  Jessica McHugh
Journal:  Nat Rev Rheumatol       Date:  2017-06-01       Impact factor: 20.543

2.  Macrophages Promote Growth of Squamous Cancer Independent of T cells.

Authors:  F L Wu; K Nolan; A A Strait; L Bian; K A Nguyen; J H Wang; A Jimeno; H M Zhou; C D Young; X J Wang
Journal:  J Dent Res       Date:  2019-06-12       Impact factor: 6.116

Review 3.  Synovial tissue macrophages: friend or foe?

Authors:  Mariola Kurowska-Stolarska; Stefano Alivernini
Journal:  RMD Open       Date:  2017-12-06

Review 4.  Synovial Macrophages in Rheumatoid Arthritis: The Past, Present, and Future.

Authors:  Jiajie Tu; Xinming Wang; Xun Gong; Wenming Hong; Dafei Han; Yilong Fang; Yawei Guo; Wei Wei
Journal:  Mediators Inflamm       Date:  2020-04-13       Impact factor: 4.711

5.  Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.

Authors:  Weiwei Liu; Yajie Zhang; Weina Zhu; Chunhua Ma; Jie Ruan; Hongyan Long; Yue Wang
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

6.  BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages.

Authors:  Jie Li; Liansheng Zhang; Yongwei Zheng; Rui Shao; Qianqian Liang; Weida Yu; Hongyan Wang; Weiguo Zou; Demin Wang; Jialing Xiang; Anning Lin
Journal:  Elife       Date:  2020-12-03       Impact factor: 8.140

Review 7.  Communications Between Bone Marrow Macrophages and Bone Cells in Bone Remodeling.

Authors:  Kaixuan Chen; Yurui Jiao; Ling Liu; Mei Huang; Chen He; Wenzhen He; Jing Hou; Mi Yang; Xianghang Luo; Changjun Li
Journal:  Front Cell Dev Biol       Date:  2020-12-22

8.  hnRNPK knockdown alleviates NLRP3 inflammasome priming by repressing FLIP expression in Raw264.7 macrophages.

Authors:  Junxia Feng; Hongyan Li; Jingchun Li; Ping Meng; Lina Wang; Chunli Liu; Shili Zhao; Wei Sun; Yunfang Zhang
Journal:  Redox Rep       Date:  2020-12       Impact factor: 4.412

9.  Proteoglycan-4 is an essential regulator of synovial macrophage polarization and inflammatory macrophage joint infiltration.

Authors:  Marwa Qadri; Gregory D Jay; Ling X Zhang; Tannin A Schmidt; Jennifer Totonchy; Khaled A Elsaid
Journal:  Arthritis Res Ther       Date:  2021-09-14       Impact factor: 5.156

10.  Synovial Macrophages: Past Life, Current Situation, and Application in Inflammatory Arthritis.

Authors:  Lin-Kun Bai; Ya-Zhen Su; Xue-Xue Wang; Bing Bai; Cheng-Qiang Zhang; Li-Yun Zhang; Gai-Lian Zhang
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.